DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
P••••••• P•••••••
Healthcare & Pharmaceuticalsgroup grade Aon a schedule nowsponsor unattributed
Also written as: P••••••• P••••••• Acquisition, LLC
Nothing material in the last 200 days. No dated change on record yet.
Mark path, consensus per quarter end
101¢ · 101¢ · 101¢ · 101¢ · 100¢Q2 2025 to Q2 2026
Where each lender marks it, 0 points apart
100¢100¢
Principal held
at least $3.8M
sum of BDC pieces, a lower bound
Fair value
$3.6M
100c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
3
3 on the latest quarter
Facilities
4
0 equity pieces beside them
Next maturity
Feb 28, 2029
no dated debt inside 24 months
On the tape since
Mar 31, 2024
latest Jun 30, 2026
Events
2
dated, non-routine
Lender marks
each lender's own fair value over cost at Jun 30, 2026, folded to one row per lender
| Lender | Exposure | Current mark | QoQ change |
|---|---|---|---|
| B••• C•••••• P•••••• C••••• | $2.65M | 100¢ | -1 pts |
| P••• P•••••• C••••• F••• | $1.19M | 100¢ | 0 pts |
| B••• C•••••• S•••••••• F••••••• I••• | no principal filed | no cost filed | new this quarter |
Every BDC piece · 5 positions across 3 lenderslargest principal first, with instrument and rate
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| B••• C•••••• P•••••• C••••• | term loan first lien F•••• L••• S••••• S•••••• L••• S••• F•••• 1.50% S••••• 6.50% I••••••• R••• 10.17% M••••••• | $2.7M | $2.6M 100c | SOFR+650 bp |
| P••• P•••••• C••••• F••• | revolver lien unstated Due 2/28/2029 | $991,000 | $982,000 100c | S+650 bp |
| P••• P•••••• C••••• F••• | revolver lien unstated R•••••••), Due 2/28/2029 | $202,000 | $-2,000 100c | S+650 bp |
| B••• C•••••• P•••••• C••••• | revolver first lien F•••• L••• S••••• S•••••• L••• - R••••••• M••••••• D••• 2/28/2029 | Not disclosed | $-11,000 79c | S+650 bp |
| B••• C•••••• S•••••••• F••••••• I••• | revolver first lien F•••• L••• S••••• S•••••• L••• - R••••••• M••••••• D••• 2/28/2029 | Not disclosed | $-27,000 73c | S+650 bp |
Capital structure as the BDCs see it
latest quarter end Jun 30, 2026
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien | at least $2.7M | 100c | SOFR+650 bp | Feb 28, 2029 | 2 |
| revolver lien unstated | at least $1.2M | 100c | S+650 bp | Feb 28, 2029 | 1 |
| first lien revolver first lien | unknown | n/a | S+650 bp | Feb 28, 2029 | 2 |
| other lien unstated exited Jun 30, 2024 | at least $1.0M | 100c | SOFR+650 bp | Feb 28, 2029 | 1 |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2026 | 3 | $3.8M | $3.6M | 100c | 0 |
| Mar 31, 2026 | 3 | $3.9M | $3.6M | 102c | 0 |
| Dec 31, 2025 | 3 | $10.9M | $10.7M | 101c | 0 |
| Sep 30, 2025 | 3 | $10.9M | $10.7M | 101c | 0 |
All 10 quartersShow fewer
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2025 | 3 | $10.9M | $10.7M | 102c | 0 |
| Mar 31, 2025 | 3 | $12.6M | $12.4M | 102c | 0 |
| Dec 31, 2024 | 3 | $12.7M | $12.5M | 102c | 0 |
| Sep 30, 2024 | 3 | $12.7M | $12.5M | 102c | 0 |
| Jun 30, 2024 | 2 | $11.0M | $10.8M | 101c | 0 |
| Mar 31, 2024 | 1 | $9.8M | $9.8M | 102c | 0 |
What changed
- Lender left a facilityMar 31, 2025
- New lender joined a facilitySep 30, 2024
- Facility left every BDC scheduleJun 30, 2024
- New borrower on a BDC scheduleMar 31, 2024
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- P••••••• P•••••••derivedthe codename stem after legal suffixes and deal words
- Spellings
- 2 across 3 BDCsderived
- Industry
- Healthcare & Pharmaceuticalsreportedas one filer wrote it